This documentation must come from the prescribing provider and typically needs to specify the clinical reason for compounding, such as: Allergy to an inactive ingredient in the commercial product Need for a dose not available in commercial presentations Documented intolerance to the commercial delivery device Billing compounded tirzepatide through the pharmacy benefit uses standard pharmacy claim formats (NCPDP) with the compounding pharmacy NDC
The reconstituted peptide shelf life article covers general principles applicable to all peptide solutions
But for people with active cancer, a prior cancer diagnosis, or ongoing cancer treatment, NAC is something to discuss with an oncologist or healthcare provider before use
Supplements You can supplement with oral capsules, tinctures, and sublingual pills
BACH1 inhibitors One member (HPP-4382) of the synthetic small molecules targeting BACH1 was able to induce the antioxidant enzyme HO1 through NRF2 activation in human lung fibroblasts [303]
If your doctor is on our side (I know that some are) please ask them to support this petition and share it with their colleagues